Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part

被引：2
|
作者：
Hebbar, M. [1 ]
Heurgue-Berlot, A. [2 ]
Boige, V. [3 ]
Le Malicot, K. [4 ]
Bernard-Chabert, B. [2 ]
Marcus, C. [5 ]
Dharancy, S. [6 ]
Sergent, G. [7 ]
Perarnau, J. M. [8 ]
Ehrhard, F. [9 ]
Ollivier-Hourmand, I. [10 ]
Vergniol, J. [11 ]
Michel, P. [12 ]
Edeline, J. [13 ]
Rinaldi, Y. [14 ]
Seitz, J. F. [15 ]
Lepage, C. [16 ]
De Baere, T. [17 ]
机构：
[1] Ctr Hosp Huriez, Med Oncol, Lille, France
[2] Univ Hosp, Hepatol, Reims, France
[3] Gustave Roussy, Digest Oncol, Villejuif, France
[4] Federat Francophone Cancerol Digest, Biostat, Dijon, France
[5] Univ Hosp, Radiol, Reims, France
[6] Ctr Hosp Huriez, Hepatol, Lille, France
[7] Ctr Hosp Huriez, Radiol, Lille, France
[8] Univ Hosp, Gastroenterol, Tours, France
[9] Univ Hosp, Gastroenterol, Reims, France
[10] Univ Hosp, Gastroenterol, Caen, France
[11] Univ Hosp, Gastroenterol, Pessac, France
[12] Univ Hosp, Gastroenterol, Rouen, France
[13] Anticanc Ctr, Oncol, Rennes, France
[14] Hop Ambroise Pare, Gastroenterol, Marseille, France
[15] La Timone Univ Hosp, Digest Oncol, Marseille, France
[16] Univ Hosp, Gastroenterol, Dijon, France
[17] Gustave Roussy, Radiol, Villejuif, France
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31221-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2305
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [21] A RANDOMISED PHASE II TRIAL OF A DRUG ELUTING BEAD IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA BY TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
    Lencioni, Riccardo
    Malagari, Katerina
    Vogl, Thomas
    Pilleul, Frank
    Denys, Alban
    Watkinson, Anthony
    Lammer, Johannes
    HEPATOLOGY, 2009, 50 (04) : 1076A - 1076A
  • [22] A RANDOMISED PHASE II TRIAL OF A DRUG ELUTING BEAD IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA BY TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
    Lencioni, R.
    Malagari, K.
    Vogl, T.
    Pilleul, F.
    Denys, A.
    Watkinson, A.
    Lammer, J.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S41 - S41
  • [23] A PHASE IB STUDY OF PEMBROLIZUMAB FOLLOWING TRANS-ARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELLULAR CARCINOMA (HCC): PETAL.
    Pinato, David James
    Cole, Tom
    Bengsch, Bertram
    Tait, Paul
    Sayed, Anwar A.
    Abomeli, Frances
    Gramenitskaya, Daria
    Allara, Elias
    Thomas, Robert
    Ward, Caroline
    Wong, Ching N.
    Akarca, Ayse U.
    Blanco, Jesus Miguens
    Marafioti, Teresa
    Marchesi, Julian
    Sharma, Rohini
    HEPATOLOGY, 2019, 70 : 209A - 210A
  • [24] A phase Ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): PETAL.
    Fulgenzi, Claudia A. M.
    Cortellini, Alessio
    D'Alessio, Antonio
    Thomas, Robert
    Tait, Paul
    Ross, Paul J.
    Young, Anna-Mary
    Talbot, Thomas
    Goldin, Robert
    Ward, Caroline
    Bengsch, Bertram
    Sharma, Rohini
    Pinato, David J. James
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16195 - E16195
  • [25] TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial
    Andreas Erhardt
    Frank Kolligs
    Matthias Dollinger
    Eckart Schott
    Hennig Wege
    Michael Bitzer
    Christiane Gog
    Frank Lammert
    Markus Schuchmann
    Clemens Walter
    Dirk Blondin
    Christian Ohmann
    Dieter Häussinger
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 947 - 954
  • [26] TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial
    Erhardt, Andreas
    Kolligs, Frank
    Dollinger, Matthias
    Schott, Eckart
    Wege, Hennig
    Bitzer, Michael
    Gog, Christiane
    Lammert, Frank
    Schuchmann, Markus
    Walter, Clemens
    Blondin, Dirk
    Ohmann, Christian
    Haussinger, Dieter
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (05) : 947 - 954
  • [27] TACE with dicycloplatin in patients with unresectable hepatocellular carcinoma: a multicenter randomized phase II trial
    Hai-Dong Zhu
    Xiao Li
    Jian-Song Ji
    Ming Huang
    Guo-Liang Shao
    Jian Lu
    Xu-Ya Zhao
    Hai-Liang Li
    Zheng-Qiang Yang
    Jian-Fei Tu
    Jin-Mei Zhou
    Chu-Hui Zeng
    Gao-Jun Teng
    European Radiology, 2022, 32 : 7335 - 7343
  • [28] TACE with dicycloplatin in patients with unresectable hepatocellular carcinoma: a multicenter randomized phase II trial
    Zhu, Hai-Dong
    Li, Xiao
    Ji, Jian-Song
    Huang, Ming
    Shao, Guo-Liang
    Lu, Jian
    Zhao, Xu-Ya
    Li, Hai-Liang
    Yang, Zheng-Qiang
    Tu, Jian-Fei
    Zhou, Jin-Mei
    Zeng, Chu-Hui
    Teng, Gao-Jun
    EUROPEAN RADIOLOGY, 2022, 32 (11) : 7335 - 7343
  • [29] Envafolimab plus lenvatinib and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective, single-arm, phase II study
    Chen, Yiwen
    Zhang, Junlei
    Hu, Wendi
    Li, Xiang
    Sun, Ke
    Shen, Yan
    Zhang, Min
    Wu, Jian
    Gao, Shunliang
    Yu, Jun
    Que, Risheng
    Zhang, Yun
    Yang, Fuchun
    Xia, Weiliang
    Zhang, Aibin
    Tang, Xiaofeng
    Bai, Xueli
    Liang, Tingbo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [30] Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC) -: Results of a phase II study
    Louafi, Samy
    Boige, Valerie
    Ducreux, Michel
    Bonyhay, Luminita
    Mansourbakht, Touraj
    de Baere, Thierry
    Asnacios, Amani
    Hannoun, Laurent
    Poynard, Thierry
    Taieb, Julien
    CANCER, 2007, 109 (07) : 1384 - 1390
12345